Using Zebrafish to Combat Cognitive Decline: How a Biopharmaceutical Company Leveraged a Zebrafish Model to characterize a Compound for Neurodegenerative Disease Therapeutics
Overview: A Massachusetts biopharma company developing therapeutics for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease was able to accelerate their pre-clinical development by partnering